The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control (CDC) and the Food and Drug Administration (FDA), is inviting eligible United States small business concerns (SBCs) to prepare for the upcoming Small Business Innovation Research (SBIR) Grant opportunity, specifically under the Parent SBIR [R43/R44] Clinical Trial Not Allowed category. This funding opportunity aims to support innovative research and development projects that align with the missions of the NIH, CDC, and FDA, encouraging collaborations among small businesses with relevant technological expertise. While applications are not currently being solicited, potential applicants should note that the estimated synopsis post date is October 1, 2025, with a closing date of January 5, 2026, and an estimated award date of June 1, 2026. For further inquiries, interested parties can contact the NIH SEED Office at SEEDinfo@nih.gov or by phone at 301-827-8595.